HEADER IMMUNE SYSTEM 11-OCT-21 7SHP TITLE CRYSTAL STRUCTURE OF HSTING IN COMPLEX WITH C[2',3'-(RIBO-2'-G, XYLO- TITLE 2 3'-A)-MP](RJ244) COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON GENES PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: HSTING,ENDOPLASMIC RETICULUM INTERFERON STIMULATOR,ERIS, COMPND 5 MEDIATOR OF IRF3 ACTIVATION,HMITA,TRANSMEMBRANE PROTEIN 173; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STING1, ERIS, MITA, TMEM173; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS STING, AGONIST, CGAMP ANALOGS, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR W.XIE,L.LAMA,X.J.YANG,V.KURYAVYI,I.NUDELMAN,J.F.GLICKMAN,R.A.JONES, AUTHOR 2 T.TUSCHL,D.J.PATEL REVDAT 3 18-OCT-23 7SHP 1 REMARK REVDAT 2 16-AUG-23 7SHP 1 JRNL REVDAT 1 19-OCT-22 7SHP 0 JRNL AUTH W.XIE,L.LAMA,X.YANG,V.KURYAVYI,S.BHATTACHARYA,I.NUDELMAN, JRNL AUTH 2 G.YANG,O.OUERFELLI,J.F.GLICKMAN,R.A.JONES,T.TUSCHL,D.J.PATEL JRNL TITL ARABINOSE- AND XYLOSE-MODIFIED ANALOGS OF 2',3'-CGAMP ACT AS JRNL TITL 2 STING AGONISTS. JRNL REF CELL CHEM BIOL 2023 JRNL REFN ESSN 2451-9456 JRNL PMID 37536341 JRNL DOI 10.1016/J.CHEMBIOL.2023.07.002 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18_3855 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 36765 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1836 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.9200 - 5.1600 0.97 2702 128 0.1958 0.2021 REMARK 3 2 5.1600 - 4.1000 0.99 2722 134 0.1659 0.1886 REMARK 3 3 4.1000 - 3.5900 0.97 2651 168 0.1803 0.2218 REMARK 3 4 3.5800 - 3.2600 0.98 2672 158 0.2078 0.2540 REMARK 3 5 3.2600 - 3.0200 0.99 2698 127 0.2179 0.2879 REMARK 3 6 3.0200 - 2.8500 0.99 2690 155 0.2295 0.3110 REMARK 3 7 2.8500 - 2.7000 0.99 2740 162 0.2326 0.3030 REMARK 3 8 2.7000 - 2.5900 0.99 2684 132 0.2219 0.2821 REMARK 3 9 2.5900 - 2.4900 0.98 2691 148 0.2286 0.2842 REMARK 3 10 2.4900 - 2.4000 0.98 2701 135 0.2334 0.2661 REMARK 3 11 2.4000 - 2.3300 0.98 2664 142 0.2459 0.3268 REMARK 3 12 2.3300 - 2.2600 0.97 2657 112 0.2822 0.3408 REMARK 3 13 2.2600 - 2.2000 0.96 2657 135 0.3065 0.3722 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.306 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.046 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 5881 REMARK 3 ANGLE : 0.745 7981 REMARK 3 CHIRALITY : 0.045 874 REMARK 3 PLANARITY : 0.004 1030 REMARK 3 DIHEDRAL : 21.339 2178 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7SHP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000260292. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-FEB-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37181 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 29.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.12930 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.45050 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.740 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4LOH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM FORMATE, 20% PEG3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 65.55450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 216 REMARK 465 PRO A 217 REMARK 465 PRO A 317 REMARK 465 ALA A 318 REMARK 465 ASP A 319 REMARK 465 ASP A 320 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 GLU A 339 REMARK 465 GLU A 340 REMARK 465 VAL A 341 REMARK 465 MET B 214 REMARK 465 ALA B 215 REMARK 465 ASP B 216 REMARK 465 PRO B 317 REMARK 465 ALA B 318 REMARK 465 ASP B 319 REMARK 465 ASP B 320 REMARK 465 SER B 321 REMARK 465 GLU B 336 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 GLU B 339 REMARK 465 GLU B 340 REMARK 465 VAL B 341 REMARK 465 ALA C 318 REMARK 465 ASP C 319 REMARK 465 ASP C 320 REMARK 465 SER C 321 REMARK 465 SER C 322 REMARK 465 GLU C 337 REMARK 465 LYS C 338 REMARK 465 GLU C 339 REMARK 465 GLU C 340 REMARK 465 VAL C 341 REMARK 465 SER D 213 REMARK 465 MET D 214 REMARK 465 ALA D 215 REMARK 465 ASP D 216 REMARK 465 PRO D 217 REMARK 465 PRO D 317 REMARK 465 ALA D 318 REMARK 465 ASP D 319 REMARK 465 ASP D 320 REMARK 465 SER D 321 REMARK 465 SER D 322 REMARK 465 GLU D 337 REMARK 465 LYS D 338 REMARK 465 GLU D 339 REMARK 465 GLU D 340 REMARK 465 VAL D 341 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 225 O HOH A 501 2.11 REMARK 500 OG SER B 305 OD1 ASN B 307 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 167 -66.78 -150.88 REMARK 500 ARG A 197 145.71 74.28 REMARK 500 SER A 305 155.82 76.51 REMARK 500 GLN A 315 -141.77 -123.40 REMARK 500 GLN A 335 61.40 -116.87 REMARK 500 TYR B 167 -72.56 -146.72 REMARK 500 HIS B 185 -53.19 -122.62 REMARK 500 ARG B 197 142.69 75.66 REMARK 500 SER B 305 157.13 79.40 REMARK 500 ARG B 334 34.21 -90.00 REMARK 500 TYR C 167 -68.76 -150.07 REMARK 500 ARG C 197 145.93 74.35 REMARK 500 ASP C 216 101.28 55.70 REMARK 500 ASN C 307 21.69 91.21 REMARK 500 TYR D 167 -71.02 -145.17 REMARK 500 REMARK 500 REMARK: NULL DBREF 7SHP A 155 341 UNP Q86WV6 STING_HUMAN 155 341 DBREF 7SHP B 155 341 UNP Q86WV6 STING_HUMAN 155 341 DBREF 7SHP C 155 341 UNP Q86WV6 STING_HUMAN 155 341 DBREF 7SHP D 155 341 UNP Q86WV6 STING_HUMAN 155 341 SEQADV 7SHP SER A 154 UNP Q86WV6 EXPRESSION TAG SEQADV 7SHP SER B 154 UNP Q86WV6 EXPRESSION TAG SEQADV 7SHP SER C 154 UNP Q86WV6 EXPRESSION TAG SEQADV 7SHP SER D 154 UNP Q86WV6 EXPRESSION TAG SEQRES 1 A 188 SER VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE GLY SEQRES 2 A 188 TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA ARG ILE SEQRES 3 A 188 ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU ARG GLY SEQRES 4 A 188 ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO LEU ASP SEQRES 5 A 188 CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP PRO ASN SEQRES 6 A 188 ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR GLY ASP SEQRES 7 A 188 HIS ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SER ILE SEQRES 8 A 188 TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY THR CYS SEQRES 9 A 188 VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE ALA SEQRES 10 A 188 MET SER GLN TYR SER GLN ALA GLY PHE SER ARG GLU ASP SEQRES 11 A 188 ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU GLU SEQRES 12 A 188 ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN ASN CYS SEQRES 13 A 188 ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SER SER SEQRES 14 A 188 PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU ARG GLN SEQRES 15 A 188 GLU GLU LYS GLU GLU VAL SEQRES 1 B 188 SER VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE GLY SEQRES 2 B 188 TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA ARG ILE SEQRES 3 B 188 ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU ARG GLY SEQRES 4 B 188 ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO LEU ASP SEQRES 5 B 188 CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP PRO ASN SEQRES 6 B 188 ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR GLY ASP SEQRES 7 B 188 HIS ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SER ILE SEQRES 8 B 188 TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY THR CYS SEQRES 9 B 188 VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE ALA SEQRES 10 B 188 MET SER GLN TYR SER GLN ALA GLY PHE SER ARG GLU ASP SEQRES 11 B 188 ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU GLU SEQRES 12 B 188 ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN ASN CYS SEQRES 13 B 188 ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SER SER SEQRES 14 B 188 PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU ARG GLN SEQRES 15 B 188 GLU GLU LYS GLU GLU VAL SEQRES 1 C 188 SER VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE GLY SEQRES 2 C 188 TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA ARG ILE SEQRES 3 C 188 ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU ARG GLY SEQRES 4 C 188 ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO LEU ASP SEQRES 5 C 188 CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP PRO ASN SEQRES 6 C 188 ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR GLY ASP SEQRES 7 C 188 HIS ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SER ILE SEQRES 8 C 188 TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY THR CYS SEQRES 9 C 188 VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE ALA SEQRES 10 C 188 MET SER GLN TYR SER GLN ALA GLY PHE SER ARG GLU ASP SEQRES 11 C 188 ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU GLU SEQRES 12 C 188 ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN ASN CYS SEQRES 13 C 188 ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SER SER SEQRES 14 C 188 PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU ARG GLN SEQRES 15 C 188 GLU GLU LYS GLU GLU VAL SEQRES 1 D 188 SER VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE GLY SEQRES 2 D 188 TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA ARG ILE SEQRES 3 D 188 ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU ARG GLY SEQRES 4 D 188 ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO LEU ASP SEQRES 5 D 188 CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP PRO ASN SEQRES 6 D 188 ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR GLY ASP SEQRES 7 D 188 HIS ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SER ILE SEQRES 8 D 188 TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY THR CYS SEQRES 9 D 188 VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE ALA SEQRES 10 D 188 MET SER GLN TYR SER GLN ALA GLY PHE SER ARG GLU ASP SEQRES 11 D 188 ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU GLU SEQRES 12 D 188 ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN ASN CYS SEQRES 13 D 188 ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SER SER SEQRES 14 D 188 PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU ARG GLN SEQRES 15 D 188 GLU GLU LYS GLU GLU VAL HET 9UR A 401 45 HET 9UR D 401 45 HETNAM 9UR (2S,5R,7R,8R,10S,12AR,14R,15R,15AR,16R)-7-(2-AMINO-6- HETNAM 2 9UR OXO-3,6-DIHYDRO-9H-PURIN-9-YL)-14-(6-AMINO-9H-PURIN-9- HETNAM 3 9UR YL)-2,10,15,16-TETRAHYDROXYOCTAHYDRO-2H,10H,12H-5,8- HETNAM 4 9UR METHANO-2LAMBDA~5~,10LAMBDA~5~-FURO[3,2-L][1,3,6,9,11, HETNAM 5 9UR 2,10]PENTAOXADIPHOSPHACYCLOTETRADECINE-2,10-DIONE FORMUL 5 9UR 2(C20 H24 N10 O13 P2) FORMUL 7 HOH *184(H2 O) HELIX 1 AA1 SER A 154 GLY A 166 1 13 HELIX 2 AA2 TYR A 167 HIS A 185 1 19 HELIX 3 AA3 HIS A 185 GLY A 192 1 8 HELIX 4 AA4 THR A 263 TYR A 274 1 12 HELIX 5 AA5 SER A 275 GLY A 278 5 4 HELIX 6 AA6 SER A 280 ALA A 302 1 23 HELIX 7 AA7 SER A 324 ARG A 334 1 11 HELIX 8 AA8 VAL B 155 GLY B 166 1 12 HELIX 9 AA9 TYR B 167 HIS B 185 1 19 HELIX 10 AB1 THR B 263 TYR B 274 1 12 HELIX 11 AB2 SER B 275 GLY B 278 5 4 HELIX 12 AB3 SER B 280 ASP B 301 1 22 HELIX 13 AB4 SER B 305 ASN B 307 5 3 HELIX 14 AB5 SER B 324 ARG B 334 1 11 HELIX 15 AB6 VAL C 155 TYR C 167 1 13 HELIX 16 AB7 TYR C 167 HIS C 185 1 19 HELIX 17 AB8 TYR C 186 ARG C 191 5 6 HELIX 18 AB9 THR C 263 TYR C 274 1 12 HELIX 19 AC1 SER C 275 GLY C 278 5 4 HELIX 20 AC2 SER C 280 ALA C 302 1 23 HELIX 21 AC3 SER C 324 ARG C 334 1 11 HELIX 22 AC4 VAL D 155 GLY D 166 1 12 HELIX 23 AC5 TYR D 167 TYR D 186 1 20 HELIX 24 AC6 THR D 263 TYR D 274 1 12 HELIX 25 AC7 SER D 275 GLY D 278 5 4 HELIX 26 AC8 SER D 280 ALA D 302 1 23 HELIX 27 AC9 SER D 324 ARG D 334 1 11 SHEET 1 AA1 5 ILE A 219 LYS A 224 0 SHEET 2 AA1 5 SER A 243 GLU A 249 -1 O ILE A 244 N ASP A 223 SHEET 3 AA1 5 GLN A 252 TYR A 261 -1 O ALA A 254 N LEU A 247 SHEET 4 AA1 5 LEU A 198 PRO A 203 1 N LEU A 201 O GLU A 260 SHEET 5 AA1 5 CYS A 309 TYR A 314 1 O ARG A 310 N LEU A 198 SHEET 1 AA2 2 GLN A 228 HIS A 232 0 SHEET 2 AA2 2 ILE A 235 TYR A 240 -1 O ARG A 238 N GLY A 230 SHEET 1 AA3 5 ILE B 219 LYS B 224 0 SHEET 2 AA3 5 SER B 243 GLU B 249 -1 O ILE B 244 N ASP B 223 SHEET 3 AA3 5 GLN B 252 TYR B 261 -1 O ALA B 254 N LEU B 247 SHEET 4 AA3 5 LEU B 198 PRO B 203 1 N LEU B 201 O GLU B 260 SHEET 5 AA3 5 CYS B 309 TYR B 314 1 O ILE B 312 N LEU B 202 SHEET 1 AA4 2 GLN B 228 HIS B 232 0 SHEET 2 AA4 2 ILE B 235 TYR B 240 -1 O TYR B 240 N GLN B 228 SHEET 1 AA5 5 ILE C 219 LYS C 224 0 SHEET 2 AA5 5 SER C 243 GLU C 249 -1 O ILE C 244 N ASP C 223 SHEET 3 AA5 5 GLN C 252 TYR C 261 -1 O ALA C 254 N LEU C 247 SHEET 4 AA5 5 LEU C 198 PRO C 203 1 N LEU C 201 O GLU C 260 SHEET 5 AA5 5 CYS C 309 TYR C 314 1 O ILE C 312 N LEU C 202 SHEET 1 AA6 2 GLN C 228 HIS C 232 0 SHEET 2 AA6 2 ILE C 235 TYR C 240 -1 O TYR C 240 N GLN C 228 SHEET 1 AA7 5 ILE D 219 LYS D 224 0 SHEET 2 AA7 5 SER D 243 GLU D 249 -1 O ILE D 244 N ASP D 223 SHEET 3 AA7 5 GLN D 252 TYR D 261 -1 O GLY D 255 N LEU D 247 SHEET 4 AA7 5 LEU D 198 PRO D 203 1 N TYR D 199 O VAL D 258 SHEET 5 AA7 5 CYS D 309 TYR D 314 1 O ILE D 312 N LEU D 202 SHEET 1 AA8 2 GLN D 228 HIS D 232 0 SHEET 2 AA8 2 ILE D 235 TYR D 240 -1 O TYR D 240 N GLN D 228 CRYST1 36.611 131.109 78.517 90.00 92.08 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027314 0.000000 0.000992 0.00000 SCALE2 0.000000 0.007627 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012744 0.00000